Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2012
02/16/2012US20120040906 Protein targets in disease
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
02/16/2012US20120040865 Target substance detection method using aptamer
02/16/2012US20120040864 Method for Determining the Cbl-b Expression
02/16/2012US20120040862 Method for detecting and quantifying endogenous wheat dna sequence
02/16/2012US20120040858 Biomarkers for stroke
02/16/2012US20120040854 Method for in vitro diagnosis or prognosis of testicular cancer
02/16/2012US20120040852 Biomarkers
02/16/2012US20120040845 Advanced pathogen testing and carcass-certification methods for slaughter operations
02/16/2012US20120040597 Carcass cutting methods and apparatus
02/16/2012US20120040476 Immunoassay reagent for kl-6 assay
02/16/2012US20120040474 Glycan-Specific Analytical Tools
02/16/2012US20120040467 Oxidation state sensors and methods for transition metal alloys
02/16/2012US20120040466 Analytical Method of Hemoglobin
02/16/2012US20120040446 Particle agglutination in a tip
02/16/2012US20120040444 Method and apparatus for preparing cells for microtome sectioning and archiving nucleic acids and proteins
02/16/2012US20120040391 Sepsis diagnostic test
02/16/2012US20120040390 Method for Introducing Protein and/or Peptide Into Cell
02/16/2012US20120040389 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins
02/16/2012US20120040383 Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer
02/16/2012US20120040382 Method of detecting progression of a neurodementing disease
02/16/2012US20120040381 Predicting mortality and detecting severe disease
02/16/2012US20120040379 Methods for differentiating plasma- derived protein from recombinant protein in a sample
02/16/2012US20120040378 Meprobromate Immunoassay
02/16/2012US20120040377 Recognition of cyp2e1 epitopes
02/16/2012US20120040376 Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect
02/16/2012US20120040375 Anti-muc1 antibody
02/16/2012US20120040374 Method for detecting renal disease comprising measuring human megalin in urine
02/16/2012US20120040373 Integrated Diagnosis of Heparin-Induced Thrombocytopenia
02/16/2012US20120040372 Receptor tyrosine kinase assays
02/16/2012US20120040371 Diagnosis of preeclampsia
02/16/2012US20120040369 On-board control detection
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040362 Multipotent Lymphohematopoietic Progenitor Cells
02/16/2012US20120040361 Methods and compositions for detection of lethal system and uses thereof
02/16/2012US20120040356 Methods for Detecting Oncofetal Fibronectin
02/16/2012US20120040355 Ykl-40 as a marker for selection of treatment and monitoring of a disease
02/16/2012US20120040354 Methods of classifying the severity of diseases or disorders
02/16/2012US20120040338 RBM3 in Testicular Cancer Diagnostics and Prognostics
02/16/2012US20120040336 Lateral Flow Assays for Non-Diagnostic Analytes
02/16/2012US20120040060 System and method for lean recovery using non invasive sensors
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039901 Method for the prevention and treatment of cancer by inhibition of gpvi
02/16/2012US20120039900 Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
02/16/2012US20120039895 Phosphorycholine conjugates and corresponding antibodies
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039891 Methods for diagnosing cancer and decreasing metastasis by cancer cells
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039885 Composition and method for cancer treatment
02/16/2012US20120039879 Streptavidin having low immunogenicity and use thereof
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039865 Identification of sortilin as a neuronal receptor for the frontotemporal dementia protein, progranulin
02/16/2012US20120039864 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
02/16/2012US20120039811 Markers for cancer detection
02/16/2012US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
02/16/2012US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof
02/16/2012US20120039767 Sensing element for cyclic saturated hydrocarbons optical detector which uses the same
02/16/2012US20120039748 Automatic analysis apparatus
02/16/2012US20120037816 Measuring device for determination of at least one parameter of a blood sample
02/16/2012US20120037516 Hydrogen sensing apparatus and method
02/16/2012US20120037515 Impedimetric sensors using dielectric nanoparticles
02/16/2012US20120037514 Enzymatic Electrochemical Biosensor
02/16/2012US20120037513 Diagnostic multi-layer dry phase test strip with integrated biosensors ("electrostrip")
02/16/2012US20120037506 METHOD OF MEASURING HEMATOCRIT (Hct), SENSOR USED IN THE METHOD, AND MEASURING DEVICE
02/16/2012US20120036946 Fingerprint detection
02/16/2012DE102010046284B3 Apparatus, useful for preparing food samples for microbiological examination, comprises hermetically closable trained transport container having a closure means, with which the container is closable after loading with sample bag
02/16/2012DE102010037009A1 Verfahren zur Analyse einer Probe A method for analyzing a sample
02/16/2012DE102010034256A1 Luminescent substance exhibiting a host lattice doped with a luminescent activator, useful in a diagnostic or therapeutic method or a tissue labeling method in vivo or in vitro, where the diagnostic method is graphical angiographic method
02/16/2012DE102010034133A1 Method for detecting e.g. diesel in fuel delivery system of internal combustion engine, involves determining sound velocity from running time, and determining expected fuel as fuel existing in fuel delivery system of engine
02/16/2012DE102007056875B4 Affinitätsstrukturen zur spezifischen Bindung von Substanzen durch nicht-kovalente Interaktionsformen Structures affinity for the specific binding of substances by non-covalent interaction forms
02/16/2012DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
02/16/2012CA2845280A1 Therapeutic uses of microvesicles and related micrornas
02/16/2012CA2843684A1 Compositions, kits and methods for treatment of complement-related disorders
02/16/2012CA2808192A1 Compositions and methods for treating cardiovascular disease
02/16/2012CA2807926A1 Method for diagnosing neurodegenerative diseases
02/16/2012CA2807918A1 New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias
02/16/2012CA2807673A1 Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
02/16/2012CA2807192A1 Devices and methods for controlling actin filaments growth and organization using micropatterned nucleation sites
02/16/2012CA2807133A1 Method for measuring glycated hemoglobin
02/16/2012CA2806640A1 Anti-tenascin-c a2 antibodies and methods of use
02/16/2012CA2806447A1 Neuropilin as a biomarker for bevacizumab combination therapies
02/16/2012CA2806381A1 Biomarkers for the early detection of breast cancer
02/16/2012CA2805803A1 Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity